Journal of Experimental & Clinical Cancer Research,
Journal Year:
2024,
Volume and Issue:
43(1)
Published: Aug. 22, 2024
Abstract
Renal
cell
carcinoma
(RCC)
is
one
of
the
most
common
tumors
that
afflicts
urinary
system,
accounting
for
90–95%
kidney
cancer
cases.
Although
its
incidence
has
increased
over
past
decades,
pathogenesis
still
unclear.
Tumor-associated
macrophages
(TAMs)
are
prominent
immune
cells
in
tumor
microenvironment
(TME),
comprising
more
than
50%
volume.
By
interacting
with
cells,
TAMs
can
be
polarized
into
two
distinct
phenotypes,
M1-type
and
M2-type
TAMs.
In
TME,
TAMs,
which
known
to
promote
tumorigenesis,
abundant
suppress
growth.
This
ratio
M1
M2
create
an
immunosuppressive
environment
contributes
progression
survival.
review
focused
on
role
RCC,
including
their
polarization,
impacts
proliferation,
angiogenesis,
invasion,
migration,
drug
resistance,
immunosuppression.
addition,
we
discussed
potential
targeting
clinical
therapy
RCC.
A
deeper
understanding
molecular
biology
essential
exploring
innovative
therapeutic
strategies
treatment
Signal Transduction and Targeted Therapy,
Journal Year:
2024,
Volume and Issue:
9(1)
Published: Aug. 2, 2024
Abstract
Metastasis
remains
a
pivotal
characteristic
of
cancer
and
is
the
primary
contributor
to
cancer-associated
mortality.
Despite
its
significance,
mechanisms
governing
metastasis
are
not
fully
elucidated.
Contemporary
findings
in
domain
biology
have
shed
light
on
molecular
aspects
this
intricate
process.
Tumor
cells
undergoing
invasion
engage
with
other
cellular
entities
proteins
en
route
their
destination.
Insights
into
these
engagements
enhanced
our
comprehension
principles
directing
movement
adaptability
metastatic
cells.
The
tumor
microenvironment
plays
role
facilitating
proliferation
by
enabling
navigate
through
stromal
barriers.
Such
attributes
influenced
genetic
epigenetic
changes
occurring
surrounding
milieu.
A
profound
understanding
process’s
biological
indispensable
for
devising
efficacious
therapeutic
strategies.
This
review
delves
recent
developments
concerning
metastasis-associated
genes,
important
signaling
pathways,
microenvironment,
metabolic
processes,
peripheral
immunity,
mechanical
forces
metastasis.
In
addition,
we
combine
advances
particular
emphasis
prospect
developing
effective
interventions
including
most
popular
immunotherapies
nanotechnology
combat
We
also
identified
limitations
current
research
metastasis,
encompassing
drug
resistance,
restricted
animal
models,
inadequate
biomarkers
early
detection
methods,
as
well
heterogeneity
among
others.
It
anticipated
that
comprehensive
will
significantly
contribute
advancement
research.
Journal of Experimental & Clinical Cancer Research,
Journal Year:
2023,
Volume and Issue:
42(1)
Published: July 6, 2023
The
management
of
advanced
clear
cell
renal
carcinoma
(ccRCC)
remains
a
major
challenge
in
clinical
practice,
and
the
construction
more
reliable
prognostic
prediction
models
further
elucidation
key
molecular
mechanisms
tumor
progression
are
topics
urgent
need
in-depth
investigation.We
used
CIBERSORT
to
estimate
proportion
22
tumor-infiltrating
immune
types
TCGA-KIRC
cohort.
Weighted
gene
co-expression
network
analysis,
least
absolute
shrinkage
selection
operator
regression
analysis
were
build
risk
models.
Expression
patterns
significance
TRAF2
determined
through
bioinformatics
real-time
qPCR,
Western
Blot,
immunohistochemistry.
GSEA
transmission
electron
microscopy,
2D/3D
colony
formation
assay,
migration
invasion
tube-formation
assay
investigate
underlying
function
mechanism
TRAF2/M2
macrophage/autophagy
axis.We
constructed
novel
model
based
on
M2
macrophage-related
genes,
which
was
identified
as
an
accurate,
independent
specific
for
ccRCC
patients.
A
nomogram
predict
1-,
3-,
5-year
overall
survival
patients
with
ccRCC.
As
one
constituent
genes
model,
be
upregulated
associated
poor
prognosis.
We
found
that
promotes
malignant
by
regulating
macrophage
polarization,
angiogenesis.
Mechanistically,
we
polarization
macrophages,
this
chemotaxis
is
achieved
autophagy-dependent
pathway.
Orthotopic
growth
results
revealed
plays
role
promotor
metastasis.In
conclusion,
highly
predictive
patients,
expected
promote
improved
treatment
evaluation
comprehensive
Moreover,
our
findings
reveal
axis
regulatory
ccRCC,
suggest
potential
therapeutic
target
Heliyon,
Journal Year:
2024,
Volume and Issue:
10(7), P. e28332 - e28332
Published: March 22, 2024
M1/M2
paradigm
of
macrophage
plasticity
has
existed
for
decades.
Now
it
becomes
clear
that
this
dichotomy
doesn't
adequately
reflect
the
diversity
phenotypes
in
tumor
microenvironment
(TME).
Tumor-associated
macrophages
(TAMs)
are
a
major
population
innate
immune
cells
TME
promotes
cell
proliferation,
angiogenesis
and
lymphangiogenesis,
invasion
metastatic
niche
formation,
as
well
response
to
anti-tumor
therapy.
However,
fundamental
restriction
therapeutic
TAM
targeting
is
limited
knowledge
about
specific
states
distinct
human
cancer
types.
Here
we
summarized
results
most
recent
studies
use
advanced
technologies
(e.g.
single-cell
RNA
sequencing
spatial
transcriptomics)
allowing
decipher
novel
functional
subsets
TAMs
numerous
cancers.
The
transcriptomic
profiles
these
their
clinical
significance
were
described.
We
emphasized
characteristics
subpopulations
–
TREM2+,
SPP1+,
MARCO+,
FOLR2+,
SIGLEC1+,
APOC1+,
C1QC+,
others,
which
have
been
extensively
characterized
several
cancers,
associated
with
prognosis.
Spatial
transcriptomics
defined
interactions
between
other
types,
especially
fibroblasts,
tumors.
methods
also
applied
identify
markers
immunotherapy
response,
expressed
by
or
macrophage-abundant
regions.
highlighted
perspectives
techniques
utilize
single
resolution
investigating
new
ligand-receptor
effective
based
on
TAM-targeting.
Medicine,
Journal Year:
2025,
Volume and Issue:
104(6), P. e41503 - e41503
Published: Feb. 7, 2025
Acute-on-chronic
liver
failure
(ACLF)
is
the
major
cause
of
mortality
in
patients
infected
with
hepatitis
B
virus
(HBV);
however,
early
determination
prognosis
HBV-ACLF
insensitive
or
limited.
This
study
aimed
to
analyze
differentially
expressed
proteins
plasma
using
data-independent
acquisition
mass
spectrometry
provide
a
reference
for
short-term
prognosis.
Fifty
and
15
healthy
controls
were
enrolled
this
study.
Of
these,
10
5
volunteers
participated
acquisition-based
proteomics
potential
core
screened
out
via
bioinformatics.
Apolipoprotein
C3
(APOC3)
was
selected
quantified
by
enzyme
linked
immunosorbent
assays
all
patients.
And
area
under
curve
(AUC)
calculated
evaluate
value
APOC3
diagnosis
HBV-ACLF.
A
total
247
identified
serum
normal
control
groups.
148
upregulated
99
downregulated
group
compared
those
group.
The
expression
level
1.65
±
0.44
mg/mL
HBV-ACLF,
which
obviously
lower
than
(2.04
0.22
mg/mL)
(
P
<
.001)
(AUC
0.766,
sensitivity
62%,
specificity
93.3%).
1.38
non-survival
group,
survival
(1.83
0.35
.0001)
0.780,
50%,
96.7%).
associated
can
be
used
as
prognostic
biomarker
Cells,
Journal Year:
2025,
Volume and Issue:
14(4), P. 253 - 253
Published: Feb. 11, 2025
Hepatocellular
carcinoma
(HCC)
poses
a
substantial
global
health
burden,
with
poor
prognosis
and
high
mortality
rates.
Dysregulated
lipid
metabolism
has
emerged
as
critical
driver
of
HCC
progression.
While
mTORC1
signaling
is
known
to
promote
synthesis
in
HCC,
the
regulatory
mechanisms
governing
remain
largely
unclear.
Here,
we
demonstrate
that
inhibition
significantly
reduces
lipogenesis
uncover
axis
involving
transcription
factor
ATF3
leucine–arginine
transporter
SLC7A7.
Transcriptomic
analysis
patients
reveals
an
inverse
correlation
between
expression
synthesis,
finding
corroborated
by
experimental
validation.
Mechanistically,
suppresses
signaling,
thereby
inhibiting
biosynthesis,
SLC7A7
identified
key
intermediary
this
process.
Specifically,
binds
enhancer
region
SLC7A7,
driving
its
transcriptional
activation
subsequently
restraining
activity.
Functional
assays
ATF3-overexpressing
-knockdown
cell
lines
further
confirm
ATF3′s
role
tumor
suppressor.
Our
study
identifies
novel
ATF3-SLC7A7-mTORC1
attenuates
tumorigenesis
establishing
link
hepatocarcinogenesis.
These
findings
offer
new
insights
into
potential
therapeutic
targets
for
treatment
HCC.
Pharmacological Research,
Journal Year:
2023,
Volume and Issue:
199, P. 107022 - 107022
Published: Dec. 1, 2023
Macrophages,
as
highly
phenotypic
plastic
immune
cells,
play
diverse
roles
in
different
pathological
conditions.
Changing
and
controlling
the
phenotypes
of
macrophages
is
considered
a
novel
potential
therapeutic
intervention.
Meanwhile,
specific
transmembrane
proteins
anchoring
on
surface
macrophage
membrane
are
relatively
conserved,
supporting
its
functional
properties,
such
inflammatory
chemotaxis
tumor
targeting.
Thus,
series
drug
delivery
systems
related
to
commonly
used
treat
chronic
diseases.
This
review
summarizes
macrophages-based
strategies
for
diseases,
discusses
regulation
their
polarization
processes,
presents
how
design
apply
site-specific
targeted
vivo
based
derived
receptors.
It
aims
provide
better
understanding
immunoregulation
proposes
approaches
BMC Cancer,
Journal Year:
2024,
Volume and Issue:
24(1)
Published: March 21, 2024
Abstract
Background
Recent
studies
have
demonstrated
that
APOC1
is
associated
with
cancer
progression,
exerting
cancer-promoting
and
immune
infiltration-promoting
effects.
Nevertheless,
there
currently
no
report
on
the
presence
of
in
ovarian
(OV).
Method
In
this
study,
we
conducted
data
analysis
using
GEO
TCGA
databases.
We
a
thorough
bioinformatics
to
investigate
function
OV,
utilizing
various
platforms
including
cBioPortal,
STRING,
GeneMANIA,
LinkedOmics,
GSCALite,
TIMER,
CellMarker.
Additionally,
performed
immunohistochemical
staining
tissue
microarrays
vitro
cellular
assays
validate
our
findings.
Result
Our
findings
reveal
expression
significantly
upregulated
OV
compared
normal
tissues.
Importantly,
patients
high
levels
show
poorer
prognosis.
Furthermore,
study
exerted
crucial
promoting
capacity
cells
proliferate,
migrate,
invade.
identified
genes
co-expressed
are
primarily
adaptive
responses.
Notably,
exhibit
correlation
M2
Tumor-associated
Macrophages
(TAMs).
Conclusion
emerges
as
promising
prognostic
biomarker
for
exhibits
significant
association
TAMs
OV.
Frontiers in Genetics,
Journal Year:
2022,
Volume and Issue:
13
Published: Oct. 18, 2022
As
a
key
copper
homeostasis-related
molecule,
lipoyltransferase
1
(LIPT1)
is
an
essential
enzyme
for
the
activation
of
mitochondrial
2-ketoacid
dehydrogenase,
participating
in
fatty
acylation.
However,
biological
significances
LIPT1
pan-cancer
are
unclear.
Here,
we
comprehensively
analyzed
functional
characteristics
human
cancers
and
its
roles
immune
response.
We
found
that
was
down-regulated
some
cancers.
And
overexpression
associated
with
favorable
prognosis
these
patients,
such
as
breast
cancer,
clear
cell
renal
carcinoma,
ovarian
cancer
gastric
cancer.
also
explored
mutational
status
methylation
levels
Gene
enrichment
analysis
indicated
abnormally
expressed
significantly
cells
infiltration,
B
cells,
CD8
+
T
cancer-associated
fibroblast
cells.
The
result
from
single
sequencing
reflected
important
regulation
several
behaviors
DNA
damage
response
apoptosis.
Taken
together,
our
research
could
provide
comprehensive
overview
about
progression,
immune.
Frontiers in Cell and Developmental Biology,
Journal Year:
2023,
Volume and Issue:
11
Published: Oct. 26, 2023
Tumour-Associated
Macrophages
(TAMs)
are
one
of
the
pivotal
components
tumour
microenvironment.
Their
roles
in
cancer
immunity
complicated,
both
pro-tumour
and
anti-cancer
activities
reported,
including
not
only
angiogenesis,
extracellular
matrix
remodeling,
immunosuppression,
drug
resistance
but
also
phagocytosis
regression.
Interestingly,
TAMs
highly
dynamic
versatile
solid
tumours.
They
show
or
activities,
interplay
between
microenvironment
stem
cells
under
specific
conditions.
In
addition
to
classic
M1/M2
phenotypes,
a
number
novel
dedifferentiation
phenomena
discovered
due
advanced
single-cell
technology,
e.g.,
macrophage-myofibroblast
transition
(MMT)
macrophage-neuron
(MNT).
More
importantly,
emerging
information
demonstrated
potential
on
immunotherapy,
suggesting
by
therapeutic
efficiency
checkpoint
inhibitors
chimeric
antigen
receptor
engineered
based
macrophages.
Here,
we
summarized
latest
discoveries
from
basic
translational
research
discussed
their
clinical
relevance
for
cancers.
Heliyon,
Journal Year:
2024,
Volume and Issue:
10(7), P. e29273 - e29273
Published: April 1, 2024
BackgroundOesophageal
squamous
cell
carcinoma
(ESCC)
is
a
leading
cause
of
cancer-related
deaths
worldwide
because
existing
treatments
are
often
insufficient.
Therefore,
new,
reliable
biomarkers
must
be
identified.
CTSL
overexpression
closely
associated
with
tumour
progression
and
poor
prognosis.
However,
the
role
mechanism
as
an
oncogene
in
ESCC
remain
unclear.MethodsGenome-wide
association
study
(GWAS)
data
were
used
for
Mendelian
randomization
analysis
to
investigate
possible
relationships
between
ESCC.
The
correlation
expression
prognosis
was
analysed
using
GEO,
TCGA,
GEPIA
data.
We
compared
among
types
single-cell
sequencing.
Correlations
microenvironment,
immune
infiltration,
mutational
load,
immunological
checkpoints,
treatment
sensitivity
patients
investigated.
Finally,
mouse
models
cellular
investigations,
we
assessed
effects
on
growth,
apoptosis,
metastasis
cells.ResultsCTSL
overexpressed
correlated
also
discovered
its
close
immunity,
especially
tumour-associated
macrophages
checkpoints
microenvironment.
may
play
key
development
by
affecting
M2
macrophage
polarisation.
marker
genes
showed
significant
positive
correlations.
confirmed
relationship
our
vitro
vivo
experiments
demonstrated
that
promoted
proliferation
migration
cells,
validating
bioinformatic
analysis.ConclusionCTSL
emerged
crucial
gene
influences
patient
particularly
macrophages.
targeting
or
modulating
levels
provide
new
therapeutic
strategies